Dudediligence.

Champions Oncology, Inc

CSBRNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
FilingsNewest: 10-Q, Quarterly reportSep 11 →InsidersNo open-market buys or sales.→HoldersBattery 17.4%Nea 12.3%Vanguard 2.2%→

From the filings

Figures

Revenue
$60.7Mlast 12 months
Net income
$69,825last 12 months
Operating cash flow
−$5.6Mlast 12 months
Cash and equivalents
$4.4Mat the last balance sheet
Shares outstanding
13.9M shareson issue
Every year and quarter →